474 related articles for article (PubMed ID: 21060071)
1. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction.
Rauch B; Schiele R; Schneider S; Diller F; Victor N; Gohlke H; Gottwik M; Steinbeck G; Del Castillo U; Sack R; Worth H; Katus H; Spitzer W; Sabin G; Senges J;
Circulation; 2010 Nov; 122(21):2152-9. PubMed ID: 21060071
[TBL] [Abstract][Full Text] [Related]
2. Highly purified omega-3 fatty acids for secondary prevention of sudden cardiac death after myocardial infarction-aims and methods of the OMEGA-study.
Rauch B; Schiele R; Schneider S; Gohlke H; Diller F; Gottwik M; Steinbeck G; Heer T; Katus H; Zimmer R; Erdogan A; Pfafferott C; Senges J;
Cardiovasc Drugs Ther; 2006 Oct; 20(5):365-75. PubMed ID: 17124558
[TBL] [Abstract][Full Text] [Related]
3. Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial.
Heydari B; Abdullah S; Pottala JV; Shah R; Abbasi S; Mandry D; Francis SA; Lumish H; Ghoshhajra BB; Hoffmann U; Appelbaum E; Feng JH; Blankstein R; Steigner M; McConnell JP; Harris W; Antman EM; Jerosch-Herold M; Kwong RY
Circulation; 2016 Aug; 134(5):378-91. PubMed ID: 27482002
[TBL] [Abstract][Full Text] [Related]
4. Letter by Halcox regarding article, "OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction".
Halcox JP
Circulation; 2011 Jul; 124(1):e21; author reply e24-5. PubMed ID: 21730312
[No Abstract] [Full Text] [Related]
5. Letter by Alter and Rupp regarding article, "OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction".
Alter P; Rupp H
Circulation; 2011 Jul; 124(1):e23; author reply e24-5. PubMed ID: 21730314
[No Abstract] [Full Text] [Related]
6. Letter by Papageorgiou et al regarding article, "OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction".
Papageorgiou N; Tousoulis D; Stefanadis C
Circulation; 2011 Jul; 124(1):e22; author reply e24-5. PubMed ID: 21730313
[No Abstract] [Full Text] [Related]
7. Predictors of 1-year mortality in patients with contemporary guideline-adherent therapy after acute myocardial infarction: results from the OMEGA study.
Liosis S; Bauer T; Schiele R; Gohlke H; Gottwik M; Katus H; Sabin G; Zahn R; Schneider S; Rauch B; Senges J; Zeymer U
Clin Res Cardiol; 2013 Sep; 102(9):671-7. PubMed ID: 23740196
[TBL] [Abstract][Full Text] [Related]
8. Effects of 1-year treatment with highly purified omega-3 fatty acids on depression after myocardial infarction: results from the OMEGA trial.
Zimmer R; Riemer T; Rauch B; Schneider S; Schiele R; Gohlke H; Diller F; Steinbeck G; Katus H; Senges J;
J Clin Psychiatry; 2013 Nov; 74(11):e1037-45. PubMed ID: 24330904
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 polyunsaturated fatty acid supplementation improves lipid metabolism and endothelial function by providing a beneficial eicosanoid-pattern in patients with acute myocardial infarction: A randomized, controlled trial.
Yuan M; Zhang Y; Hua T; Liu XL; Liu T; Yuan RY; Li GP; Zhu Y; Zhang X
Clin Nutr; 2021 Feb; 40(2):445-459. PubMed ID: 33041091
[TBL] [Abstract][Full Text] [Related]
10. Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction: A Randomized, Controlled Trial.
Kalstad AA; Myhre PL; Laake K; Tveit SH; Schmidt EB; Smith P; Nilsen DWT; Tveit A; Fagerland MW; Solheim S; Seljeflot I; Arnesen H;
Circulation; 2021 Feb; 143(6):528-539. PubMed ID: 33191772
[TBL] [Abstract][Full Text] [Related]
11. Plasma Omega-3 Fatty Acids and the Risk of Cardiovascular Events in Patients After an Acute Coronary Syndrome in MERLIN-TIMI 36.
Zelniker TA; Morrow DA; Scirica BM; Furtado JD; Guo J; Mozaffarian D; Sabatine MS; O'Donoghue ML
J Am Heart Assoc; 2021 Apr; 10(8):e017401. PubMed ID: 33840228
[TBL] [Abstract][Full Text] [Related]
12. [Sudden cardiac death after myocardial infarct. ICD and omega 3 fatty acids without preventive effect].
Einecke D
MMW Fortschr Med; 2009 Apr; 151(16):14. PubMed ID: 19658288
[No Abstract] [Full Text] [Related]
13. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.
Marchioli R; Barzi F; Bomba E; Chieffo C; Di Gregorio D; Di Mascio R; Franzosi MG; Geraci E; Levantesi G; Maggioni AP; Mantini L; Marfisi RM; Mastrogiuseppe G; Mininni N; Nicolosi GL; Santini M; Schweiger C; Tavazzi L; Tognoni G; Tucci C; Valagussa F;
Circulation; 2002 Apr; 105(16):1897-903. PubMed ID: 11997274
[TBL] [Abstract][Full Text] [Related]
14. Effects of omega-3 fatty acid for sudden cardiac death prevention in patients with cardiovascular disease: a contemporary meta-analysis of randomized, controlled trials.
Chen Q; Cheng LQ; Xiao TH; Zhang YX; Zhu M; Zhang R; Li K; Wang Y; Li Y
Cardiovasc Drugs Ther; 2011 Jun; 25(3):259-65. PubMed ID: 21626218
[TBL] [Abstract][Full Text] [Related]
15. [Influence of ω-3 PUFAs on predictors of sudden cardiac death in patients with Q-wave myocardial infarction].
Logacheva IV; Barantseva NG; Vinokurova ES
Kardiologiia; 2012; 52(12):17-23. PubMed ID: 23237436
[TBL] [Abstract][Full Text] [Related]
16. Long-chain omega-3 fatty acids from fish reduce sudden cardiac death in patients with coronary heart disease.
Richter WO
Eur J Med Res; 2003 Aug; 8(8):332-6. PubMed ID: 12915328
[TBL] [Abstract][Full Text] [Related]
17. Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial.
O'Donoghue ML; Glaser R; Cavender MA; Aylward PE; Bonaca MP; Budaj A; Davies RY; Dellborg M; Fox KA; Gutierrez JA; Hamm C; Kiss RG; Kovar F; Kuder JF; Im KA; Lepore JJ; Lopez-Sendon JL; Ophuis TO; Parkhomenko A; Shannon JB; Spinar J; Tanguay JF; Ruda M; Steg PG; Theroux P; Wiviott SD; Laws I; Sabatine MS; Morrow DA;
JAMA; 2016 Apr; 315(15):1591-9. PubMed ID: 27043082
[TBL] [Abstract][Full Text] [Related]
18. Genetic profiling of fatty acid desaturase polymorphisms identifies patients who may benefit from high-dose omega-3 fatty acids in cardiac remodeling after acute myocardial infarction-Post-hoc analysis from the OMEGA-REMODEL randomized controlled trial.
Kwong RY; Heydari B; Ge Y; Abdullah S; Fujikura K; Kaneko K; Harris WS; Jerosch-Herold M; Antman EM; Seidman JG; Pfeffer MA
PLoS One; 2019; 14(9):e0222061. PubMed ID: 31532795
[TBL] [Abstract][Full Text] [Related]
19. Highly purified omega-3 polyunsaturated fatty acids are effective as adjunct therapy for secondary prevention of myocardial infarction.
Verboom CN;
Herz; 2006 Dec; 31 Suppl 3():49-59. PubMed ID: 17575805
[TBL] [Abstract][Full Text] [Related]
20. Effects of ω3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled study.
Laake K; Myhre P; Nordby LM; Seljeflot I; Abdelnoor M; Smith P; Tveit A; Arnesen H; Solheim S
BMC Geriatr; 2014 Jun; 14():74. PubMed ID: 24928284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
